Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment

MM Mehanna, HA Elmaradny… - Drug development and …, 2010 - Taylor & Francis
Background: Mucoadhesive drug delivery is a promising strategy to overcome ocular
biopharmaceutical constraints. Objective and methods: Ciprofloxacin HCl-loaded reverse …

Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies

RS Bhatta, H Chandasana, YS Chhonker… - International journal of …, 2012 - Elsevier
The aim of this study was to prepare natamycin encapsulated lecithin/chitosan
mucoadhesive nanoparticles (NPs) for prolonged ocular application. These NPs were …

Strategies for improving ocular drug bioavailability and corneal wound healing with chitosan-based delivery systems

T Irimia, MV Ghica, L Popa, V Anuţa, AL Arsene… - Polymers, 2018 - mdpi.com
The main inconvenience of conventional eye drops is the rapid washout of the drugs due to
nasolacrimal drainage or ophthalmic barriers. The ocular drug bioavailability can be …

Mucoadhesive chitosan–dextran sulfate nanoparticles for sustained drug delivery to the ocular surface

W Chaiyasan, SP Srinivas… - Journal of ocular …, 2013 - liebertpub.com
Purpose: To characterize nanoparticles produced by self-assembly of oppositely charged
polymers, cationic chitosan (CS), and anionic dextran sulfate (DS), for drug delivery to the …

Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy

HK Ibrahim, IS El-Leithy, AA Makky - Molecular pharmaceutics, 2010 - ACS Publications
A fluoroquinolone/glucocorticoid combination for the treatment of bacterial keratitis in the
form of mucoadhesive nanoparticle suspensions was developed to prolong the release and …

Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes

G Abdelbary - Pharmaceutical development and technology, 2011 - Taylor & Francis
The aim of this work is to improve the ocular bioavailability of ciprofloxacin hydrochloride
(CPX) through the preparation of ocular mucoadhesive chitosan (CS)-coated liposomes …

Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation

S Wadhwa, R Paliwal, SR Paliwal… - Journal of drug …, 2010 - Taylor & Francis
In clinical practices, solution of dorzolamide hydrochloride (DH) and timolol maléate (TM) is
recommended for the treatment of glaucoma. However, low drug-contact time and poor …

Chitosan-based nanostructures: a delivery platform for ocular therapeutics

M de la Fuente, M Raviña, P Paolicelli… - Advanced drug delivery …, 2010 - Elsevier
Nanoscience and nanotechnology has caused important breakthroughs in different
therapeutic areas. In particular, the application of nanotechnology in ophthalmology has led …

Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and …

Ameeduzzafar, NK Alruwaili, SS Imam, NH Alotaibi… - AAPS …, 2020 - Springer
Ciprofloxacin is a commonly used antibiotic for treatment of bacterial conjunctivitis. The
conventional eye drop dosage form is the widely used mode of treatment, but it has low …

The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa

AM De Campos, A Sánchez, R Gref, P Calvo… - European journal of …, 2003 - Elsevier
The influence of the surface characteristics of colloidal drug carriers in their interaction with
different biological surfaces is becoming increasingly evident. In order to investigate the …